Akt Stimulates Aerobic Glycolysis in Cancer Cells
暂无分享,去创建一个
A. Alavi | C. Rudin | C. Thompson | R. Elstrom | D. E. Bauer | M. Buzzai | Robyn Karnauskas | M. H. Harris | D. Plas | H. Zhuang | Ryan M. Cinalli | C. Thompson | C. Thompson
[1] O. Warburg. [Origin of cancer cells]. , 1956, Oncologia.
[2] S. Staal. Molecular cloning of the akt oncogene and its human homologues AKT1 and AKT2: amplification of AKT1 in a primary human gastric adenocarcinoma. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[3] David L. Vaux,et al. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.
[4] Erwin G. Van Meir,et al. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. , 1992, Cancer research.
[5] J. Cheng,et al. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[6] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[7] A. Agustí,et al. Oxygen conformance of cellular respiration in hepatocytes. , 1993, The American journal of physiology.
[8] J. Hoflack,et al. Methods for biochemical study of poly(ADP-ribose) metabolism in vitro and in vivo. , 1995, Analytical biochemistry.
[9] J. Cheng,et al. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas , 1995, International journal of cancer.
[10] J. Cheng,et al. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[11] S. Rosenberg,et al. implications for cancer therapy , 1996 .
[12] Saroj P. Mathupala,et al. Aberrant Glycolytic Metabolism of Cancer Cells: A Remarkable Coordination of Genetic, Transcriptional, Post-translational, and Mutational Events That Lead to a Critical Role for Type II Hexokinase , 1997, Journal of bioenergetics and biomembranes.
[13] David R. Kaplan,et al. Regulation of Neuronal Survival by the Serine-Threonine Protein Kinase Akt , 1997, Science.
[14] J. Cheng,et al. Transforming activity and mitosis-related expression of the AKT2 oncogene: evidence suggesting a link between cell cycle regulation and oncogenesis , 1997, Oncogene.
[15] R A Jungmann,et al. c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[16] C. Dang,et al. A unique glucose-dependent apoptotic pathway induced by c-Myc. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[17] A. Merlo,et al. Frequent Co‐Alterations of TP53, p16/CDKN2A, p14ARF, PTEN Tumor Suppressor Genes in Human Glioma Cell Lines. , 1999, Brain pathology.
[18] G. Semenza,et al. Oncogenic alterations of metabolism. , 1999, Trends in biochemical sciences.
[19] A. Koong,et al. Loss of PTEN facilitates HIF-1-mediated gene expression. , 2000, Genes & development.
[20] G. Semenza,et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. , 2000, Cancer research.
[21] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[22] C. Dang,et al. Deregulation of Glucose Transporter 1 and Glycolytic Gene Expression by c-Myc* , 2000, The Journal of Biological Chemistry.
[23] A. Harris,et al. Effects of ras and von Hippel-Lindau (VHL) gene mutations on hypoxia-inducible factor (HIF)-1alpha, HIF-2alpha, and vascular endothelial growth factor expression and their regulation by the phosphatidylinositol 3'-kinase/Akt signaling pathway. , 2001, Cancer research.
[24] C. Thompson,et al. Akt and Bcl-xL Promote Growth Factor-independent Survival through Distinct Effects on Mitochondrial Physiology* , 2001, The Journal of Biological Chemistry.
[25] A. Harris,et al. Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[26] E. Kandel,et al. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase. , 2001, Genes & development.
[27] C. Thompson,et al. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. , 2002, Molecular biology of the cell.
[28] B. Hemmings,et al. Inhibition of protein kinase B/Akt. implications for cancer therapy. , 2002, Pharmacology & therapeutics.
[29] Roman Ludwig,et al. Invasion and metastasis in pancreatic cancer , 2003, Molecular Cancer.
[30] D. Averill-Bates,et al. Heat shock inactivates cellular antioxidant defenses against hydrogen peroxide: protection by glucose. , 2002, Free radical biology & medicine.
[31] R. Klausner. The fabric of cancer cell biology-Weaving together the strands. , 2002, Cancer cell.
[32] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[33] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.
[34] C. Thompson,et al. Phosphatidylinositol 3-Kinase/Akt Signaling Is Neither Required for Hypoxic Stabilization of HIF-1α nor Sufficient for HIF-1-dependent Target Gene Transcription* , 2002, The Journal of Biological Chemistry.
[35] P. Hammerman,et al. Akt-Directed Glucose Metabolism Can Prevent Bax Conformation Change and Promote Growth Factor-Independent Survival , 2003, Molecular and Cellular Biology.
[36] C. Rudin,et al. Bcl-xL and Akt cooperate to promote leukemogenesis in vivo , 2003, Oncogene.
[37] A. Alavi,et al. Utility of FDG-PET scanning in lymphoma by WHO classification. , 2003, Blood.
[38] C. Thompson,et al. Activated Akt promotes increased resting T cell size, CD28‐independent T cell growth, and development of autoimmunity and lymphoma , 2003, European journal of immunology.
[39] N. Tribolet,et al. Characterization of an established human malignant glioma cell line: LN-18 , 2004, Acta Neuropathologica.